1. Home
  2. GKOS vs FCN Comparison

GKOS vs FCN Comparison

Compare GKOS & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • FCN
  • Stock Information
  • Founded
  • GKOS 1998
  • FCN 1982
  • Country
  • GKOS United States
  • FCN United States
  • Employees
  • GKOS N/A
  • FCN N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • FCN Professional Services
  • Sector
  • GKOS Health Care
  • FCN Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • FCN Nasdaq
  • Market Cap
  • GKOS 8.4B
  • FCN 7.0B
  • IPO Year
  • GKOS 2015
  • FCN 1996
  • Fundamental
  • Price
  • GKOS $156.36
  • FCN $190.50
  • Analyst Decision
  • GKOS Strong Buy
  • FCN Strong Buy
  • Analyst Count
  • GKOS 13
  • FCN 1
  • Target Price
  • GKOS $147.23
  • FCN $275.00
  • AVG Volume (30 Days)
  • GKOS 662.3K
  • FCN 250.7K
  • Earning Date
  • GKOS 02-19-2025
  • FCN 02-20-2025
  • Dividend Yield
  • GKOS N/A
  • FCN N/A
  • EPS Growth
  • GKOS N/A
  • FCN 28.86
  • EPS
  • GKOS N/A
  • FCN 8.71
  • Revenue
  • GKOS $360,347,000.00
  • FCN $3,728,412,000.00
  • Revenue This Year
  • GKOS $22.69
  • FCN $7.62
  • Revenue Next Year
  • GKOS $26.76
  • FCN $4.98
  • P/E Ratio
  • GKOS N/A
  • FCN $21.88
  • Revenue Growth
  • GKOS 18.70
  • FCN 11.66
  • 52 Week Low
  • GKOS $83.90
  • FCN $185.93
  • 52 Week High
  • GKOS $161.13
  • FCN $243.60
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 60.10
  • FCN 41.05
  • Support Level
  • GKOS $142.71
  • FCN $190.90
  • Resistance Level
  • GKOS $158.01
  • FCN $197.54
  • Average True Range (ATR)
  • GKOS 4.96
  • FCN 3.54
  • MACD
  • GKOS -0.16
  • FCN 0.38
  • Stochastic Oscillator
  • GKOS 74.10
  • FCN 14.19

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance and restructuring, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: